Filing Details
- Accession Number:
- 0000899243-21-035508
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-09 21:34:50
- Reporting Period:
- 2021-09-07
- Accepted Time:
- 2021-09-09 21:34:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1802665 | Harmony Biosciences Holdings Inc. | HRMY | Pharmaceutical Preparations (2834) | 822279923 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1821102 | Jeffrey Dierks | 630 W. Germantown Pike, Suite 215 Plymouth Meeting PA 19462 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-09-07 | 5,000 | $8.22 | 5,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-09-07 | 5,000 | $37.00 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2021-09-07 | 4,083 | $0.00 | 4,083 | $8.22 |
| Common Stock | Stock Option | Disposition | 2021-09-07 | 917 | $0.00 | 917 | $8.22 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 7,304 | 2028-10-01 | No | 4 | M | Direct | |
| 23,428 | 2030-03-04 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- The stock option is currently vested with respect to 4,868 shares, and will vest with respect to the remainder of the shares in three equal annual installments beginning on October 1, 2021.
- The stock option is currently vested with respect to 4,869 shares, and will vest with respect to the remainder of the shares in four equal annual installments beginning on March 1, 2022.
- Reflects the exercise of 785 stock options on September 1, 2021, which was reported on the Form 4 filed by the reporting person on September 3, 2021, but erroneously reflected as an exercise of the tranche which expires on October 2, 2027, rather than the tranche which expires on October 1, 2028.
Billionaire Hedge Funds
